Comerica Bank
SNTI icon

Comerica Bank’s Senti Biosciences Holdings SNTI Stock Holding History

Comerica Bank’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$18 – 3808
2024
Q1 		$18 Hold
5
– – ﹤0.01% 3740
2023
Q4 		$32 Hold
5
– – ﹤0.01% 3717
2023
Q3 		$20 Buy
+5
New +$34 ﹤0.01% 3783

Other funds holding SNTI

8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Comerica Bank's SNTI Position: Q2 2024 in Review

Comerica Bank sold out of Senti Biosciences Holdings (SNTI) in Q2 2024, closing a stake of 5 shares — an estimated $18 sold.

Comerica Bank first reported a position in SNTI in Q3 2023 and held it in 3 quarters. The position peaked at $32 in Q4 2023. 20 funds tracked by Wall St. Rank hold SNTI as of Q2 2024.

  • Comerica Bank reported no remaining Senti Biosciences Holdings position as of Q2 2024 after selling out during the quarter.
  • Comerica Bank sold 5 Senti Biosciences Holdings shares in Q2 2024, an estimated $18.
  • Comerica Bank first reported a position in Senti Biosciences Holdings in Q3 2023 and held it in 3 quarters.
  • Comerica Bank's Senti Biosciences Holdings position peaked at $32 in Q4 2023.
  • 20 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2024.

Based on Comerica Bank's 13F filing for Q2 2024, filed 15 Aug 2024.